Drug recall · August 27, 2025
Albuterol Sulfate recall
Why: Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.
- Lots / codes
Lot#: 4IB0519, Exp. 04/30/2026
- Quantity
- 20352 packs (1x 200 MD)
- Company
- Cipla USA, Inc., Warren, NJ
- Distribution
- U.S. Nationwide.
- Initiated
- July 24, 2025 · Voluntary: Firm initiated
- Classified
- August 20, 2025
- Reported
- August 27, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Albuterol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.